In DN, hyperglycemia induces increased ROS production from sources such as NADPH oxidases and mitochondrial dysfunction, leading to pathological changes, including glomerulosclerosis and tubulointerstitial fibrosis [35,36,37]. The gene discussed is FMO5; the disease is glomerulosclerosis.